Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease
- PMID: 16257256
- DOI: 10.1016/j.cytogfr.2005.09.003
Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease
Abstract
The pancreas is a complex exocrine and endocrine gland that controls many homeostatic functions. The exocrine pancreas produces and secretes digestive enzymes, whereas, the endocrine pancreas produces four distinct hormones, chief among them being the glucose regulating hormone-insulin. Diabetes, pancreatitis and pancreatic cancer are some of the main afflictions that result from pancreas dysfunction. Transforming growth factor-beta (TGF-beta) proteins are central regulators of pancreas cell function, and have key roles in pancreas development and pancreatic disease. Since expression levels and kinase activities of components of TGF-beta signaling are aberrantly altered in diseases of the pancreas, modulating the activity of TGF-beta provides a unique and rational opportunity for therapeutic intervention. Although TGF-beta still remains elusive in terms of our understanding of its multifunctional modes of action, research is moving closer to the design of approaches directed toward modulating its activities for therapeutic benefit.
Similar articles
-
Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.Arch Immunol Ther Exp (Warsz). 2005 Sep-Oct;53(5):381-7. Arch Immunol Ther Exp (Warsz). 2005. PMID: 16314822 Review.
-
Aberrant gata-3 expression in human pancreatic cancer.J Histochem Cytochem. 2006 Feb;54(2):161-9. doi: 10.1369/jhc.5A6626.2005. Epub 2005 Aug 8. J Histochem Cytochem. 2006. PMID: 16087702
-
Pancreatic organogenesis--developmental mechanisms and implications for therapy.Nat Rev Genet. 2002 Jul;3(7):524-32. doi: 10.1038/nrg841. Nat Rev Genet. 2002. PMID: 12094230 Review.
-
Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1.Mol Cell Endocrinol. 2005 Jan 14;229(1-2):175-84. doi: 10.1016/j.mce.2004.08.007. Mol Cell Endocrinol. 2005. PMID: 15607541
-
Fibrogenesis in the pancreas.Rocz Akad Med Bialymst. 2004;49:40-6. Rocz Akad Med Bialymst. 2004. PMID: 15631312 Review.
Cited by
-
The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.PLoS One. 2015 Jul 30;10(7):e0132978. doi: 10.1371/journal.pone.0132978. eCollection 2015. PLoS One. 2015. PMID: 26226105 Free PMC article.
-
Intraislet Pancreatic Ducts Can Give Rise to Insulin-Positive Cells.Endocrinology. 2016 Jan;157(1):166-75. doi: 10.1210/en.2015-1175. Epub 2015 Oct 27. Endocrinology. 2016. PMID: 26505114 Free PMC article.
-
Roles for the type III TGF-beta receptor in human cancer.Cell Signal. 2010 Aug;22(8):1163-74. doi: 10.1016/j.cellsig.2010.01.016. Epub 2010 Feb 12. Cell Signal. 2010. PMID: 20153821 Free PMC article. Review.
-
A smad signaling network regulates islet cell proliferation.Diabetes. 2014 Jan;63(1):224-36. doi: 10.2337/db13-0432. Epub 2013 Oct 2. Diabetes. 2014. PMID: 24089514 Free PMC article.
-
The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.BMC Cancer. 2016 Feb 25;16:155. doi: 10.1186/s12885-016-2191-7. BMC Cancer. 2016. PMID: 26915435 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical